...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: USA ZHCLF investors

"Question; if ZCC sells ZEL does there need to be a special meeting and a shareholder vote before a deal can be consummated? My thought is no, as it would be normal course business of ZCC to sell a subsidiary. What do others think?"

That being said and Zenith Capital Corp does  sell Zenith Epigenetics at some point in the fuitre , how does that help the shareprice of ZHCLF if now it is cash rich ?? do we assume the expert market will take the new buyout of ZEL in consideration into a new Enterprise valuation. I am not too sure how this would paly out fos the retail sahreholders of ZHCLF other than if an IPO occured after the sale of ZEL

Share
New Message
Please login to post a reply